Maximizing the Value of Biospecimens to Deliver New Therapies

In his position as Director and Head of Sample Management, Dr. Clive Green is faced with a number of challenges, including AstraZeneca's transition from their research and development center in northwestern England, to a new research center to be built in Cambridge. The greater challenge going forward is, from Dr. Green's perspective, maximizing value from the biospecimens in the collection. This involves, among other issues, closing the gap in inventory management methods between the small molecule world and the world of biospecimens.

In this interview-style eBook, Clive shares his perspective on biobanking, as it compares to managing a small molecule inventory, and challenges in the biospecimen supply chain.

eBook16_Maximizing_the_Value_of_Biospecimens_to_Deliver_New_Therapies_cover

eBook download - Maximizing the Value of Biospecimens